Stock COSMO PHARMACEUTICALS S.P.A
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Cosmo Pharmaceuticals S.p.A Swiss Exchange

Equities

IT0004167463

End-of-day quote Swiss Exchange
Other stock markets
- CHF - Intraday chart for Cosmo Pharmaceuticals S.p.A
03/06 Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down MT
26/04 Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 CI

Chart calendar Cosmo Pharmaceuticals S.p.A

60be78bac.qFdB6cBiOt-cGRni6MD5jwHSSjH33rXx_84uWPhRI_U.5wQIpIslS6rMfyDWp_izwlefIQGPs8aQtLlpLJ8CQceaHimAhQMLvet7XA~e180de77a17662e913efd2ac3028f42b

Upcoming events on Cosmo Pharmaceuticals S.p.A

05/07/2024 Extraordinary Shareholders Meeting
25/07/2024 10:30 am Q2 2024 Earnings Release
19/03/2025 Q4 2024 Earnings Release (Projected)
24/07/2025 Q2 2025 Earnings Release (Projected)
19/03/2026 Q4 2025 Earnings Release (Projected)
23/07/2026 Q2 2026 Earnings Release (Projected)

Past events on Cosmo Pharmaceuticals S.p.A

06/06/2024 ODDO BHF Nextcap Forum
24/05/2024 03:30 pm Annual General Meeting
20/03/2024 07:30 pm Investor Day
20/03/2024 03:30 pm Q4 2023 Earnings Call
20/03/2024 11:30 am Q4 2023 Earnings Release
13/03/2024 J.P. Morgan Pan-European Small/Mid-Cap CEO Conference
16/01/2024 ODDO BHF Forum
05/12/2023 CF&B Communication European Midcap Conference
14/11/2023 Jefferies London Healthcare Conference
10/10/2023 Investor Meeting - Day 2
09/10/2023 Investor Meeting - Day 1
26/07/2023 05:30 pm Q2 2023 Earnings Call
26/07/2023 10:30 am Q2 2023 Earnings Release
31/05/2023 Détachement de for final dividend
26/05/2023 03:30 pm Annual General Meeting
28/03/2023 Jefferies Pan-European Mid-Cap Conference
24/03/2023 Kepler Cheuvreux Swiss Seminar
23/03/2023 06:30 pm Q4 2022 Earnings Call
23/03/2023 11:30 am Q4 2022 Earnings Release
13/03/2023 Berenberg EU Opportunities Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million EUR		Released
Forecast
Spread 		65,6
67,9
-3.32%		62,5
47,1
32.64%		60,9
53,0
14.94%		65,1
62,4
4.3%		102
101
1.31%		96,7
139
-30.49%
EBITDA
Million EUR		Released
Forecast
Spread 		-12,1
-15,4
21.25%		-6,55
-12,7
48.58%		12,9
9,31
38.99%		18,5
9,21
100.87%		41,9
39,4
6.34%		26,5
67,8
-60.94%
EBIT
Million EUR		Released
Forecast
Spread 		-16,6
-20,1
17.44%		-12,3
-17,5
29.63%		6,91
3,31
108.93%		11,1
5,31
109.26%		28,1
28,7
-2.33%		12,2
56,3
-78.29%
Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-17,5
-18,1
3.67%		-21,3
-28,8
26.11%		-6,93
-7,45
6.97%		24,0
21,0
14.3%		24,5
23,7
3.19%		7,61
63,3
-87.97%
Net income
Million EUR		Released
Forecast
Spread 		-18,1
-22,1
18.38%		-24,5
-27,6
11.25%		-7,90
-6,47
-22.12%		21,7
11,3
91.37%		17,2
21,4
-19.57%		1,15
34,5
-96.67%
EPS
EUR		Released
Forecast
Spread 		-1,20
-1,42
15.4%		-1,67
-1,83
8.71%		-0,55
-0,43
-27.57%		1,29
0,72
77.89%		1,05
1,12
-6%		0,07
0,72
-90.07%
Announcement Date29/03/1903/04/2026/03/2123/03/2223/03/2320/03/24

Quarterly results

Fiscal PeriodDecember 2019 S1 2019 S2 2020 S1 2021 S1 2022 S1 2022 S2 2023 S1 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 S2
Net sales
Million EUR		Released
Forecast
Spread 		21,5
27,2
-20.93%		41,0
23,3
75.91%		25,9
22,1
17.38%		28,4
27,9
2.05%		41,5
38,7
7.26%		60,6
58,0
4.44%		43,7
44,6
-2.11%
132


37,3


143


44,3


114

EBITDA
Million EUR		Released
Forecast
Spread


8,04
3,70
117.32%





























EBIT
Million EUR		Released
Forecast
Spread 		-17,2
-8,90
-93.27%		4,89
-0,90
643.78%		2,66
-4,20
163.38%		0,01
0,55
-98.55%		8,11
3,20
153.38%		19,9
19,5
2.3%		7,12
4,90
45.37%
108


12,0


94,6


17,4


66,9

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		-22,6
-15,9
-42.26%		1,32
-8,00
116.44%		-5,33
-8,45
36.91%		-4,67
-6,45
27.64%		9,09
-1,10
926.27%		15,4
15,6
-1.38%		3,67
1,30
182.54%






95,0





67,5

Net income
Million EUR		Released
Forecast
Spread 		-20,8
-15,9
-30.7%		-3,71
-6,55
43.33%		-3,02
-8,45
64.32%		-5,74
-6,45
10.99%		7,90
-1,10
817.82%		9,33
14,8
-36.97%		1,49
1,00
48.6%






68,4





48,6

EPS
EUR		Released
Forecast
Spread 		-1,41
-1,10
-27.91%		-0,26
-0,50
47.6%		-0,21
-0,55
61.9%		-0,40
-0,43
6.12%		0,48
-0,06
893.33%		0,57
0,90
-36.33%		0,09
0,06
53.33%






4,26





3,02

Announcement Date30/07/1903/04/2030/07/2030/07/2128/07/2223/03/2326/07/23-----

Upcoming sector events for Cosmo Pharmaceuticals S.p.A

04/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
11/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release
16/07/2024 CAMURUS AB: Q2 2024 Earnings Release
17/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 04:15 pm JOHNSON & JOHNSON: Q2 2024 Earnings Release
18/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 10:30 am NOVARTIS AG: Q2 2024 Earnings Release
22/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
22/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
23/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Cosmo Pharmaceuticals S.p.A

30/05/2024 05:38 pm SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 04:30 pm ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 11:54 am MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 05:30 pm FDC LIMITED: Q4 2024 Earnings Release
29/05/2024 02:56 pm JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release
29/05/2024 02:14 pm ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
29/05/2024 01:40 pm IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
29/05/2024 PFIZER LIMITED: Q4 2024 Earnings Release
28/05/2024 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
27/05/2024 05:40 pm ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. COPN Stock
  4. Stock
  5. Calendar Cosmo Pharmaceuticals S.p.A